Atossa Therapeutics
ATOS
ATOS
66 hedge funds and large institutions have $16.8M invested in Atossa Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 25 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
56% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 25
67% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 27
Holders
66
Holding in Top 10
–
Calls
$221K
Puts
$115K
Top Buyers
| 1 | +$214K | |
| 2 | +$202K | |
| 3 | +$145K | |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$136K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$80.1K |
Top Sellers
| 1 | -$321K | |
| 2 | -$312K | |
| 3 | -$278K | |
| 4 |
Jane Street
New York
|
-$244K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$229K |